戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ion was done in 52 (37%) of those undergoing portoenterostomy.
2 r patients (86%) had undergone prior hepatic portoenterostomy.
3 f recipient age, weight, or previous hepatic portoenterostomy.
4 autoantibodies in the first year after Kasai portoenterostomy.
5 actors that drive liver fibrosis after Kasai portoenterostomy.
6 ents with BA, collected at the time of Kasai portoenterostomy, along with liver biopsies from infants
7 d with improved outcomes following the Kasai portoenterostomy and longer survival with the native liv
8 reatment of this disease have been the Kasai portoenterostomy and orthotopic liver transplantation.
9 en will achieve biliary drainage after Kasai portoenterostomy and will have serum bilirubin within th
10 ort of subjects (6-12 months following Kasai portoenterostomy) and correlations of autoantibodies wit
11 ts depend on early referral and timely Kasai portoenterostomy, and thus a high index of suspicion is
12  study of 43 infants who underwent the Kasai portoenterostomy as treatment for biliary atresia at the
13          Despite early management with Kasai portoenterostomy , BA remains the leading indication for
14  of minimally invasive approaches to hepatic portoenterostomy but there has been little comparative s
15  recipient age, weight, and previous hepatic portoenterostomy did not.
16                                              Portoenterostomy failure warrants liver transplantation,
17 de advantages for newborn procedures such as portoenterostomy for biliary atresia and repair of esoph
18                            The outcome after portoenterostomy for biliary atresia is determined by ag
19  investigated risk factors for failure after portoenterostomy for biliary atresia using univariate an
20 tudy was the age infants underwent the Kasai portoenterostomy for treatment of biliary atresia.
21                                      Hepatic portoenterostomy generally is the initial treatment for
22                                      Kasai's portoenterostomy has gained worldwide acceptance as the
23           The determinants of the outcome of portoenterostomy include the age at surgery, the center'
24 ommonly used to predict outcomes after Kasai portoenterostomy (KP).
25 natomic features of infants undergoing Kasai portoenterostomy (KPE) for biliary atresia (BA) and to e
26                         Outcomes after Kasai portoenterostomy (KPE) for biliary atresia remain highly
27 es of surgical management, typically a Kasai portoenterostomy (KPE), vary considerably across the wor
28 ly aimed at oxidative stress) before a Kasai portoenterostomy (KPE).
29                                              Portoenterostomy may reestablish biliary drainage, but,
30                Surgical treatment, the Kasai portoenterostomy, may restore bile flow and clear jaundi
31 icting native liver survival (NLS) following portoenterostomy (PE) surgery are lacking.
32 ding transplantation as primary therapy, but portoenterostomy remains the standard of care as first-l
33 espite multiple modifications of the hepatic portoenterostomy, two thirds of treated patients still d
34            Early clearance of jaundice after portoenterostomy was achieved in 81 of 142 (57%) infants
35                                    A primary portoenterostomy was done in 142 (96%) infants and a pri
36          The age infants underwent the Kasai portoenterostomy was significantly younger after screeni